Literature DB >> 14566493

The effect of propofol infusion on minimum alveolar concentration of sevoflurane for smooth tracheal intubation.

Tsuyoshi Satsumae1, Seiji Watanabe, Hiroshi Yamaguchi.   

Abstract

PURPOSE: This study was conducted to determine the effect of propofol infusion on the minimum alveolar concentration necessary for smooth tracheal intubation (MACEI) of sevoflurane.
METHODS: Sixty-nine patients, American Society of Anesthesiologists (ASA) status I, aged 30-49 years, were randomly assigned to one of three groups according to the agents used for tracheal intubation (n = 23 for each group): the SP group, in whom the intubation was attempted under sevoflurane plus propofol infusion; the S group, tracheal intubation under sevoflurane alone; and the P group, tracheal intubation under propofol infusion alone. Anesthesia was induced with propofol 2.5 mg.kg(-1) i.v. bolus. Prior to the tracheal intubation attempt, propofol infusion, 10 mg.kg(-1).h(-1), was given for 15 min in the SP and P groups, and sevoflurane equilibration was established in the SP and S groups. All tracheal intubation attempts were made 15 min after anesthetic induction. The end-tidal sevoflurane concentration at which tracheal intubation was attempted was predetermined by the up-and-down method (with 0.5% as a step size). MACEI was determined using a logistic regression test.
RESULTS: The MACEI of sevoflurane was 1.73% in the SP group, and 2.99% in the S group. Laryngoscopy was not possible in the P group patients.
CONCLUSION: Propofol infusion reduced sevoflurane MACEI. This finding suggests that propofol would be an excellent adjuvant to use with sevoflurane for tracheal intubation.

Entities:  

Year:  2002        PMID: 14566493     DOI: 10.1007/s540-002-8091-3

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  1 in total

1.  Acute presentation of a partially obstructing laryngeal tumour: adjuvant agents to gaseous induction of anaesthesia.

Authors:  Natalie Constable; Carolyn Thomas; Martyn Jones; Matt Walters
Journal:  BMJ Case Rep       Date:  2018-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.